CDHIC National Finals Preview: The Ultimate Showdown of Healthcare Innovation Projects with a Combined Valuation Exceeding RMB 10 Billion

Traversing rivers, lakes, and seas; passing under the sun, moon, and stars. Beginning with the first regional final of the China Health and Medical Big Data Industry Innovation Competition (CDHIC) (Beijing Division Final) on July 9, we successively visited Guangzhou, Hangzhou, Chengdu, and Wuhan, before returning to Beijing to complete the specialized competition in Traditional Chinese Medicine (TCM) + TMT. Spanning two months in total, this journey brought the regional finals to a successful conclusion with a full-circle finish.

After a rigorous selection process by the organizing committee and professional judges, 30 high-quality projects emerged from six major regional divisions across China to advance to the National Finals. They will compete fiercely at the Beijing Hotel on September 8 for limited national team empowerment resources.

Nationwide Call for Entries: Covering 11 Sub-sectors, with Three Competition Categories Advancing in Tandem

Since the opening of registration for the CDHIC Competition in April, the organizing committee has received over 500 submissions of medical innovation projects, sourced through solicitations in cities including Beijing, Shenzhen, Fuzhou, Guangzhou, Hangzhou, Chengdu, Chongqing, and Wuhan, as well as recommendations from numerous investment institutions. Following rigorous preliminary screening and six regional finals held in Beijing, Guangzhou, Hangzhou, Chengdu, Wuhan, and Beijing (Traditional Chinese Medicine + TMT Special Session), 30 high-quality projects have emerged from the large pool of participants. These finalists are set to compete in the ultimate showdown in five days.

The innovative projects advancing to the finals come from ten healthcare sub-sectors, includingMedTech, Healthcare IT, Medical Devices, Pharmaceuticals, Primary Care, General Health, Maternal and Child Health, Consumer Healthcare, Pharmaceutical Distribution, and Traditional Chinese MedicineandTMT DataThe Competition Organizing Committee categorizes participating projects into three divisions—Growth Star, Angel Star, and Rising Star—based on their investment and financing rounds and specific circumstances. Within each division, projects will compete intensely for the championship, runner-up, third place, and other awards in a fair and open manner.

High-Quality Projects with a Combined Valuation Exceeding RMB 10 Billion Converge in Beijing, Showcasing Strong Capabilities Through 30 Pitch Sessions

The vast majority of the 30 projects shortlisted for the National Finals were the top three finishers in their respective regional finals, with their comprehensive strength certified by professional judges at those regional events.

According to statistics from VCBeat, innovative projects from Beijing accounted for 34% of the total shortlisted entries, making them the main force in this grand final; Shanghai followed with 17%. This indicates that in the field of healthcare innovation, Beijing and Shanghai are the primary hubs for innovative talent, as well as the regions with the highest number of innovative enterprises, the broadest distribution of innovation sectors, and the most intense competition.

Innovative projects shortlisted for the national finals generally demonstrate strong financial health, with over 80% having successfully secured investment and financing. The total valuation of these projects exceeds RMB 10 billion. Among them, 24% have completed Series A financing, 31% have completed Series B financing, and 14% have completed Series C or later-stage financing. Additionally, more than 60% of the projects report annual revenues exceeding RMB 5 million, reflecting steady overall revenue growth and attracting significant attention from professional investors.

Furthermore, in addition to establishing their headquarters in China, some of the companies behind these projects have set up overseas branches, subsidiaries, or research institutes, leveraging extensive domestic and international resources for innovative research. Regarding the core teams, 35 founders and key R&D personnel from the shortlisted projects hold master’s or doctoral degrees from China’s prestigious “985” and “211” universities, while 24 others hold advanced degrees from renowned overseas institutions. This abundance of talent underscores their strong innovation and R&D capabilities. Moreover, over 70% of the enterprises have mature products and operational models, with some having established collaborations with multiple hospitals and large corporations, thereby securing a stable customer base. More than 30% have been certified as National High-Tech Enterprises. Some companies possess independent intellectual property rights, have obtained certifications such as CFDA approval, EU CE marking, ISO9001, ISO14001, ISO13485, and ISO27001, or have participated in or led the formulation of industry and international standards. Each project boasts distinct highlights and demonstrates robust comprehensive strength.

List of Finalists in the National Finals of the China Health and Medical Big Data Industry Innovation Competition

Thirty professional judges and fifteen investment observers each provided rigorous scoring, with an innovative competition format ensuring fair matchups among projects.

The National Finals invited thirty professional judges, including leaders from national enterprises and public institutions, heads of industry-related associations, executives and senior experts from major industry corporations, and leaders from the host and co-organizing entities. Additionally, fifteen senior investors were selected and invited from over seventy investment firms to serve as Investment Observers, jointly evaluating the competing projects. Each project is scored out of a maximum of 100 points, with professional judges accounting for 85% of the total score and Investment Observers accounting for 15%. Each professional judge strictly evaluates projects across six dimensions: technology and service model (20 points), business model (20 points), management team (20 points), industry and market (15 points), financial analysis (15 points), and on-site Q&A performance (10 points). The final professional judge score for each project is calculated by taking the weighted average after removing the highest and lowest scores, then multiplying this average by 85%. Each Investment Observer may give “likes” based on project performance, with each like counting as one point. The maximum number of likes per project is capped at 15 points. The final score for each project is the sum of the professional judge score and the Investment Observer score. The Organizing Committee will rank projects within each of the three categories based on these final scores and award championships, runner-ups, third-place winners, and other honors accordingly.

Official Website:http://vcbeat.top/cdhic

Organization Profile

1. Chinese Society for Health Informatics and Medical Big Data

The Chinese Society for Health Informatics and Medical Big Data is a national first-tier academic society under the administration of the National Health Commission. Guided by the principles of implementing national health and wellness policies, strategies, and plans, and aligning with the developmental needs of the health sector, the Society focuses on research, development, application, and practice in health and family planning statistics, informatization construction, and health and medical big data. Its mission is to enhance the professional standards of health statistics, informatization, and health and medical big data; to improve the expertise of personnel in these fields; to promote the dissemination and adoption of related knowledge; and to advance the nation’s healthcare standards as well as the modernization of management and theoretical frameworks in national health and wellness. Ultimately, the Society is dedicated to serving the Healthy China strategy by boosting public sense of gain, injecting new momentum into deepening healthcare reform, and fostering new drivers for economic growth.

2. China Electronics Corporation

China Electronics Corporation (CEC), established in May 1989, is committed to building a national team for the cybersecurity and informatization industry. With cybersecurity as its core business and competency, CEC’s main operations span strategic, foundational, and pioneering sectors of the electronic information industry, including cybersecurity, next-generation displays, integrated circuits, advanced electronics, and information services. Currently, CEC has 20 wholly-owned and controlled secondary subsidiaries, controls 14 listed companies, and employs a total of 130,000 people.

(1) Industry Position

China Electronics Corporation (CEC) is China's largest state-owned comprehensive electronic information enterprise group and has been listed among the Fortune Global 500 for seven consecutive years.

(2) Cybersecurity Field

China Electronics Corporation (CEC) is a leading domestic provider of autonomous and controllable hardware and software products, as well as information security services. It possesses a controllable software industry chain spanning operating systems, middleware, databases, security products, and application systems, thereby establishing a comprehensive information security service system that covers the full lifecycle, including security consulting, system integration, and security operations and maintenance.

(3) New Display Technologies

CEC is a globally leading integrated R&D, manufacturer, and supplier of LCD products, ranking first worldwide in LCD monitor manufacturing services and third globally in LCD TV manufacturing.

(4) Integrated Circuit Sector

China Electronics is a leading domestic provider of comprehensive solutions for the research, design, and manufacturing of integrated circuits (ICs), and the only enterprise in China that covers the entire IC industry chain, including design, manufacturing, packaging, testing, EDA tools, and process R&D.

(5) Information Services Sector

China Electronics is a leading domestic provider of trade and services for electronic information products, a builder and operator of high-tech, innovative industrial parks, a constructor of overseas electronic informationization projects and services, and a financial innovation platform for the electronic information industry.

As one of the first batches of “Innovative Enterprises” in China, China Electronics Corporation (CEC) has established a comprehensive technological innovation system, comprising three tiers of R&D institutions: national-level research institutes, the Group’s specialized technical research academies, and enterprise technology centers. Currently, the Group operates 7 nationally recognized enterprise technology centers, 8 national engineering research centers (including engineering laboratories and engineering technology research centers), 5 national innovation demonstration enterprises, 1 national-level industrial design center, 12 postdoctoral workstations, and 70 provincial- and ministerial-level technology centers.

3. China Electronics Data

China Electronics Data Service Co., Ltd. (hereinafter referred to as “CEC Data”) is a national team for the development of the health and medical big data industry, spearheaded by China Electronics Corporation under the guidance of the National Health Commission. Adhering to the principle of “security first, data services, platform operations, and ecosystem development,” the company focuses on building two core capabilities: “security” and “intelligence.” CEC Data has become:

(1) National High-Tech Enterprise and Zhongguancun High-Tech Enterprise;

(2) The entity responsible for the planning, construction, and operation of the National Pilot Project for the Construction of the National Health and Medical Big Data Center and Industrial Park (Fuzhou);

(3) The sole implementing entity for the national “Internet+ Healthcare” major project;

(4) Co-construction Unit of the National Engineering Laboratory for Medical Big Data Application Technology;

(5) Secretariat Unit of the Professional Committee on Health and Medical Big Data Industry Development and Information Security, Chinese Society for Health Informatics and Medical Big Data (China Health and Medical Big Data Industry Alliance).

Adhering to the philosophy of ecological development and collaborative innovation, the company continuously builds and refines a comprehensive ecosystem centered on healthcare big data, encompassing ten key pillars: security, intelligence, Internet of Things (IoT), mass entrepreneurship and innovation, finance, culture and education, national projects, transaction services, new technologies, and local specialties. In partnership with domestic and international institutions such as IBM, Philips, Tencent, Peking University Data Institute, Tsinghua University Data Institute, WuXi AppTec, Sequoia Capital, and Medlinker, the company jointly constructs a robust healthcare big data ecosystem.

4. CEC Digital Finance

To foster an industrial ecosystem for big data in healthcare, China Electronics Data initiated the establishment of the CE Healthcare Big Data (Hangzhou) Equity Investment Fund Partnership (Limited Partnership) (hereinafter referred to as the “CE Healthcare Fund”) and its management company, CE Shurong Investment Management (Hangzhou) Co., Ltd., in June 2017. The fund has a management scale of RMB 3 billion. As a key capital link in China Electronics Data’s ecological layout, the CE Healthcare Fund focuses on investing in highly relevant sectors radiating from the healthcare data industry, including Fintech, Biotech, artificial intelligence, and next-generation internet technologies.

Leveraging the advantages of CEC Data as a national team in healthcare big data, the fund centers on data as its core resource and builds an integrated ecosystem encompassing business, data, and capital through the convergence of industry and finance. It provides robust value-added services to support and incubate partners and portfolio companies within this ecosystem, thereby achieving shared business opportunities, shared benefits, and synergistic ecological development.

The fund has currently completed strategic investments in Medlinker, Senyi Intelligence, Unisound, Beiken Technology, and Chuanshi Boruo.

CEC Digital Finance was honored as one of the “Top 10 Emerging Private Equity Investment Firms in China” and one of the “Top 10 Best Investment Firms in the Medical Services Sector of China’s Healthcare and Health Services Industry” by China Venture for 2017.

5. MedLink

Medlinker is China’s leading real-name physician platform, boasting over 500,000 verified physicians and 20,000 contracted physicians. Built on this physician platform and driven by core resources and technologies such as medical big data and artificial intelligence, Medlinker is continuously refining its full industry chain with a focus on smart internet hospital solutions. Its business footprint is progressively expanding across upstream and downstream segments of the broader healthcare industry, including government agencies, healthcare institutions, pharmaceutical and medical device manufacturers, and insurance companies, thereby accelerating the realization of value through connectivity, integration, and empowerment.

6. Qihuang Traditional Chinese Medicine Foundation

Beijing Qihuang Traditional Chinese Medicine Culture Development Foundation, established in July 2009, is a non-public fundraising charitable foundation initiated by entrepreneur Mr. Gong Xiaodong and approved by the Beijing Municipal Civil Affairs Bureau. It is a non-profit, non-governmental organization.

The Foundation is dedicated to advancing cultural, educational, and healthcare initiatives related to the inheritance of classic Traditional Chinese Medicine (TCM) theories, the dissemination of TCM culture, and the promotion of excellent TCM diagnostic and therapeutic techniques. Since its establishment, the Foundation has accumulated over RMB 10 million in public welfare expenditures.

Upholding the mission of “promoting the inheritance and development of Traditional Chinese Medicine (TCM) and carrying forward TCM’s traditional culture,” the Foundation has established extensive communication and cooperation with the TCM community both in China and abroad, and is emerging as a significant force in advancing the development of TCM’s traditional culture.

7. Danxi Technology

Beijing Qianyuan Danxi Technology Co., Ltd. has established collaborations with over 100 teams of nationally renowned senior TCM practitioners, leveraging nine years of accumulated experience in public welfare initiatives within the traditional Chinese medicine (TCM) community. The company has also forged business partnerships with the National Administration of Traditional Chinese Medicine, the China Association of Chinese Medicine, major TCM universities, and related institutions. Danxi Technology is committed to building a comprehensive ecosystem for high-quality TCM-style living, integrating “technology + content + products + services” based on the TCM industry and the internet. Simultaneously, it strategically positions big data, public welfare, and cultural initiatives as foundational pillars supporting this ecosystem, ensuring coordinated development across all sectors to advance the implementation of the Healthy China national strategy of “universal access to TCM services.” The company aims to develop technological products that closely align with the genuine needs of the TCM community, facilitating a more seamless integration of traditional TCM practices with modern technology.

8. Tasly Capital

Tasly Capital, established in 2007 as a subsidiary of Tasly Holding Group, currently manages five RMB-denominated funds and three USD-denominated funds, with total assets under management exceeding RMB 10 billion. Leveraging the resources accumulated by the Tasly Group in pharmaceuticals, traditional Chinese medicine (TCM) materials, and pharmaceutical sales, Tasly Capital’s investment portfolio is strategically focused on six core sectors: pharmaceutical manufacturing, pharmaceutical commerce, healthcare services, digital health innovation, TCM materials, and health supplements. Pioneering the industry-first “Patient-Centric 4D Investment Model,” Tasly Capital centers its investments around four key pillars: Diagnosis, Drug, Device, and Digital services. This approach aims to capitalize on structural adjustments driven by transformations in the healthcare industry, focus on consumption upgrades among the middle class, secure new entry points for patient engagement, and facilitate the cross-sector integration of emerging technologies with the healthcare industry.

9. Zhongguancun Technology Leasing Co., Ltd.

Zhongguancun Technology Leasing Co., Ltd. (hereinafter referred to as “Zhongguancun Leasing” or the “Company”) was established in late 2012. It is a state-controlled domestic-funded pilot enterprise for financial leasing, approved by the Ministry of Commerce and the State Administration of Taxation, with a registered capital of RMB 1 billion. As China’s first technology-focused leasing company, Zhongguancun Leasing leverages Zhongguancun Development Group, a key market-oriented integrated operation platform in the demonstration zone. Committed to “promoting the integration of technology and finance and realizing the dreams of tech entrepreneurs,” the Company specializes in providing efficient financial services and equipment leasing solutions for technology enterprises, thereby fostering mutually beneficial development between the technology and financial industries.

10. VCBeat

VCBeat is a leading content platform in China dedicated to innovation and entrepreneurship in the healthcare sector. We focus on emerging technologies and the ecological transformations they drive, exploring future trends through subtle shifts. We observe, document, reflect on, and disseminate valuable insights into the evolution of business models in future healthcare and the ethical implications behind new technologies. As observers, thinkers, and recorders of healthcare transformation, we advocate for industry evolution, uncover the logic behind events, map out the industry landscape, and provide reference benchmarks, practical case studies, and actionable methodologies for harnessing the power of innovation. Throughout our development, VCBeat has amassed extensive networking resources, forming a robust health ecosystem centered on the entrepreneurial community, with coordinated growth across investment, industrial chain, media, government, and international circles. We have accumulated over 100,000 followers, established more than 500 WeChat groups, and reached over 100,000 industry professionals, while maintaining close ties with 2,000+ startups, 1,000+ individual investors, 500+ investment firms, and 100+ industry media outlets.